These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26050117)

  • 1. Fractures in chronic kidney disease: pursuing the best screening and management.
    Goldenstein PT; Jamal SA; Moysés RM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):317-23. PubMed ID: 26050117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to predict and treat increased fracture risk in chronic kidney disease.
    West SL; Patel P; Jamal SA
    J Intern Med; 2015 Jul; 278(1):19-28. PubMed ID: 25758353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk and treatment in chronic kidney disease.
    Connelly K; Collister D; Tangri N
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):221-225. PubMed ID: 29547405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of fracture risk used to examine the link between bone mineral density and the impact of different therapeutic mechanisms on fracture outcomes in patients with osteoporosis.
    Eudy-Byrne RJ; Gillespie W; Riggs MM; Gastonguay MR
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):599-609. PubMed ID: 29081020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the management of osteoporosis in the aging female population.
    Amin U; McPartland A; O'Sullivan M; Silke C
    Womens Health (Lond); 2023; 19():17455057231176655. PubMed ID: 37218715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy for patients with CKD and low bone mineral density.
    Ott SM
    Nat Rev Nephrol; 2013 Nov; 9(11):681-92. PubMed ID: 24100401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporosis treatment for patients with chronic kidney disease].
    Konishi Y
    Nihon Rinsho; 2015 Oct; 73(10):1723-7. PubMed ID: 26529937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post hip fracture care].
    Tandjung R; Rosemann T
    Praxis (Bern 1994); 2011 Jul; 100(15):917-21. PubMed ID: 21792807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Wilson LM; Rebholz CM; Jirru E; Liu MC; Zhang A; Gayleard J; Chu Y; Robinson KA
    Ann Intern Med; 2017 May; 166(9):649-658. PubMed ID: 28395318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
    Josse R; Khan A; Ngui D; Shapiro M
    Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postmenopausal osteoporosis.
    Andreopoulou P; Bockman RS
    Annu Rev Med; 2015; 66():329-42. PubMed ID: 25386933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in CKD-Associated Osteoporosis.
    Khairallah P; Nickolas TL
    Curr Osteoporos Rep; 2018 Dec; 16(6):712-723. PubMed ID: 30353319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive approach to fragility fractures.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New Developments in CKD-MBD. Efficacy and safety of antiosteoporotic agents in CKD].
    Kazama JJ
    Clin Calcium; 2014 Dec; 24(12):1831-7. PubMed ID: 25423929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone and kidney disease: diagnostic and therapeutic implications.
    Jamal SA; West SL; Miller PD
    Curr Rheumatol Rep; 2012 Jun; 14(3):217-23. PubMed ID: 22350608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis.
    Ensrud KE; Crandall CJ
    Ann Intern Med; 2017 Aug; 167(3):ITC17-ITC32. PubMed ID: 28761958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone disease in CKD: a focus on osteoporosis diagnosis and management.
    Miller PD
    Am J Kidney Dis; 2014 Aug; 64(2):290-304. PubMed ID: 24726630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.